Lung cancer specialists' opinions on treatment for stage I non-small cell lung cancer: A multidisciplinary survey.

ABSTRACT:

Purpose

The current standard of care for surgically eligible stage I non-small cell lung cancer (NSCLC) is surgical resection, but emerging data suggest that stereotactic body radiation therapy (SBRT) is potentially as effective as surgery. However, specialist views of the current evidence about SBRT and how they would incorporate a randomized controlled trial (RCT) into practice is unclear. We sought to understand specialist opinions about evidence regarding treatment of stage I NSCLC and how this translates into practice and clinical trial implementation.

Methods and materials

We used a 28-item, web-based survey that invited all participating providers from the American Society for Radiation Oncology, American Thoracic Society Thoracic Oncology Assembly, and the Internatio

SUBMITTER: Lammers A 

PROVIDER: S-EPMC6000198 | biostudies-literature | 2018 Apr-Jun

REPOSITORIES: biostudies-literature